Botulax 200u (Letybo)

Botulax 200IU is a botulinum toxin type A injectable used for the temporary treatment of wrinkles, fine lines, and certain medical conditions such as chronic migraines, excessive sweating, and muscle spasms. With a potency of 200 units, Botulax works by temporarily blocking the signals between nerves and muscles, providing a smoother, more youthful appearance. It is widely used in aesthetic and therapeutic treatments, offering effective results with minimal downtime.

Key Benefits

• Cost-Effective Efficiency: The 200-unit vial size offers an optimal balance for treating multiple areas (e.g., full upper face) from a single vial, enhancing practice cost management without significant waste.

• High Purity & Consistency: Produced using a purified manufacturing process, Botulax is known for its reliable diffusion and consistent clinical results, supporting predictable treatment outcomes.

• Rapid Onset: Patients may notice initial effects often within 2-3 days post-treatment, with full effects typically visible within one week, contributing to high patient satisfaction.

• Versatile Application: Effective for a broad range of both aesthetic indications and therapeutic uses (e.g., hyperhidrosis, muscle spasticity), making it a versatile tool in a clinical setting.

Target Areas for Treatment

• Glabellar Complex (frown lines)
• Frontalis Muscle (horizontal forehead lines)
• Orbicularis Oculi (lateral canthal lines or "crow's feet")
• Brow Lift (chemical brow shaping)
• Bunny Lines (nasal scrunch lines)
• Perioral Rhytids (with extreme caution and micro-dosing)
• Mentalis Muscle (chin dimpling)
• Masseteric Hypertrophy (jaw slimming)
• Axillary or Palmar Hyperhidrosis (excessive sweating)

Therapeutic Applications: (Requires specific diagnosis and dosing protocols)

• Blepharospasm
• Cervical Dystonia
• Muscle Spasticity

Important Tips for Medical Practitioners

Establish Your Own Dosing Protocol: Botulax units are not interchangeable with Botox, Dysport, or other toxins. Begin with conservative, area-specific dosing based on Botulax clinical data or established peer protocols, and adjust based on individual patient response. Do not use direct 1:1 conversion ratios from other brands.

Reconstitution for Desired Effect: The volume of diluent significantly affects the concentration and spread. A moderate dilution (e.g., 2.5 mL per 100 μL vial) is a common starting point for balanced diffusion. Always use preservative-free saline.

Understand Its Characteristic: Botulax is generally noted to have a diffusion profile that is precise yet slightly broader than some counterparts. Factor this into injection point planning, especially near the orbital rim, to minimize the risk of eyelid ptosis.

Storage & Stability: Store unopened vials refrigerated between 2°C and 8°C. Post-reconstitution, stability data can vary; a standard clinical guideline is to use within 24 hours when refrigerated, but always refer to the latest manufacturer instructions.

Comprehensive Patient Assessment: As with all neuromodulators, a thorough consultation is critical. Screen for contraindications, manage expectations regarding onset and duration, and document pre-treatment status with photography. Obtain specific informed consent for off-label uses.

Disclaimer: This information is for professional educational use only. The safe and effective administration of Botulax requires appropriate medical training, licensure, and a deep understanding of facial and muscular anatomy. Alura Medical Supply distributes this product to credentialed healthcare professionals only.

units, Botulax works by temporarily blocking the signals between nerves and muscles, providing a smoother, more youthful appearance. It is widely used in aesthetic and therapeutic treatments, offering effective results with minimal downtime.

Key Benefits

• Cost-Effective Efficiency: The 200-unit vial size offers an optimal balance for treating multiple areas (e.g., full upper face) from a single vial, enhancing practice cost management without significant waste.

• High Purity & Consistency: Produced using a purified manufacturing process, Botulax is known for its reliable diffusion and consistent clinical results, supporting predictable treatment outcomes.

• Rapid Onset: Patients may notice initial effects often within 2-3 days post-treatment, with full effects typically visible within one week, contributing to high patient satisfaction.

• Versatile Application: Effective for a broad range of both aesthetic indications and therapeutic uses (e.g., hyperhidrosis, muscle spasticity), making it a versatile tool in a clinical setting.

Target Areas for Treatment

• Glabellar Complex (frown lines)
• Frontalis Muscle (horizontal forehead lines)
• Orbicularis Oculi (lateral canthal lines or "crow's feet")
• Brow Lift (chemical brow shaping)
• Bunny Lines (nasal scrunch lines)
• Perioral Rhytids (with extreme caution and micro-dosing)
• Mentalis Muscle (chin dimpling)
• Masseteric Hypertrophy (jaw slimming)
• Axillary or Palmar Hyperhidrosis (excessive sweating)

Therapeutic Applications: (Requires specific diagnosis and dosing protocols)

• Blepharospasm
• Cervical Dystonia
• Muscle Spasticity

Important Tips for Medical Practitioners

Establish Your Own Dosing Protocol: Botulax units are not interchangeable with Botox, Dysport, or other toxins. Begin with conservative, area-specific dosing based on Botulax clinical data or established peer protocols, and adjust based on individual patient response. Do not use direct 1:1 conversion ratios from other brands.

Reconstitution for Desired Effect: The volume of diluent significantly affects the concentration and spread. A moderate dilution (e.g., 2.5 mL per 100 μL vial) is a common starting point for balanced diffusion. Always use preservative-free saline.

Understand Its Characteristic: Botulax is generally noted to have a diffusion profile that is precise yet slightly broader than some counterparts. Factor this into injection point planning, especially near the orbital rim, to minimize the risk of eyelid ptosis.

Storage & Stability: Store unopened vials refrigerated between 2°C and 8°C. Post-reconstitution, stability data can vary; a standard clinical guideline is to use within 24 hours when refrigerated, but always refer to the latest manufacturer instructions.

Comprehensive Patient Assessment: As with all neuromodulators, a thorough consultation is critical. Screen for contraindications, manage expectations regarding onset and duration, and document pre-treatment status with photography. Obtain specific informed consent for off-label uses.

Disclaimer: This information is for professional educational use only. The safe and effective administration of Botulax requires appropriate medical training, licensure, and a deep understanding of facial and muscular anatomy. Alura Medical Supply distributes this product to credentialed healthcare professionals only.